Skip to main content
Home > SciBX > Therapeutics

Chronological Index of SciBX: The Science-Business eXchange: Therapeutics

SciBX: The Science-Business eXchange Current Issue
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Autoimmune disease Autoimmune disease IL-7; IL-7 receptor (IL-7R; CD127) In vitro and …

    Published on 5/16/2013
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Acute myelogenous leukemia (AML) Hemopoietic cell kinase (HCK) SAR and mouse …

    Published on 5/16/2013
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Brain cancer Dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A (…

    Published on 5/16/2013
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Breast cancer b-Catenin (CTNNB1); HER2 (EGFR2; ErbB2; neu); p21 protein (Cdc42 Rac…

    Published on 5/16/2013
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Breast cancer Discoidin domain receptor tyrosine kinase 2 (DDR2) In vitro and …

    Published on 5/16/2013
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer DNA In vitro and mouse studies suggest prodrugs of the duocarmycin family …

    Published on 5/16/2013
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Enhancer of zeste homolog 2 (EZH2); SWI/SNF-related matrix-associated actin…

    Published on 5/16/2013
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Insulin receptor substrate 1 (IRS1); phosphatidylinositol 3-kinase …

    Published on 5/16/2013
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer K-Ras; son of sevenless homolog 1 (SOS1); CRAF (RAF1) In vitro, cell …

    Published on 5/16/2013
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Toll-like receptor 5 (TLR5) Mouse studies suggest liver-targeted TLR5 …

    Published on 5/16/2013
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Multiple myeloma (MM) Carcinoembryonic antigen-related cell adhesion molecule 6 (…

    Published on 5/16/2013
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Hepatic disease Liver fibrosis Mothers against decapentaplegic homolog 3 (MADH3; SMAD3); …

    Published on 5/16/2013
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Influenza virus Toll-like receptor 4 (TLR4) Rodent studies suggest a …

    Published on 5/16/2013
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Leishmaniasis Not applicable In vitro and hamster studies suggest new…

    Published on 5/16/2013
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Viral infection Not applicable In vitro and mouse studies identified …

    Published on 5/16/2013
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Alzheimer's disease (AD) b-Amyloid (Ab) Mouse studies suggest a conjugate …

    Published on 5/16/2013
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Brain cancer H3 histone family 3A (H3.3A; H3F3A); v-myc myelocytomatosis viral related oncogene …

    Published on 5/9/2013
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Brain cancer Not applicable In vitro and mouse studies suggest inhibiting hypoxic exosomes could help treat …

    Published on 5/9/2013
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer IQ motif containing GTPase activating protein 1 (IQGAP1); MAP kinase 1 (MAPK1; ERK-2); MAPK3 (ERK-1)…

    Published on 5/9/2013
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Head and neck cancer Epidermal growth factor receptor (EGFR); hedgehog pathway Cell culture and mouse …

    Published on 5/9/2013
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Prostate cancer Androgen receptor Cell culture and mouse studies identified androgen receptor antagonists …

    Published on 5/9/2013
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Cardiomyopathy MicroRNA-146a (miR-146a) In vitro and mouse studies suggest inhibiting miR-…

    Published on 5/9/2013
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Diabetes Betatrophin Mouse studies suggest betatrophin could be useful for treating …

    Published on 5/9/2013
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Dyslipidemia; metabolic syndrome; obesity Transcription factor EB (TFEB) Mouse studies …

    Published on 5/9/2013
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Trypanosome Isoleucyl tRNA synthetase (IARS) A study in mice suggests inhibiting IARS could help…

    Published on 5/9/2013

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993

Log In


Forgot password  |  Forgot Login


If you are a subscriber, but have forgotten or never received a password, please click above to receive a new one.

SciBX: Science-Business eXchange

BioCentury's weekly translational science journal, published in collaboration with Nature Publishing Group:

  • Selects from hundreds of scientific papers published each week to identify early opportunities for investment, alliances and partnerships
  • Reports on the most commercially relevant developments